The stock has a 36-month beta value of -0.50. Opinions on the stock are mixed, with 3 analysts rating it as a “buy,” 2 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for BMEA is 28.02M, and at present, short sellers hold a 25.49% of that float. On August 28, 2024, the average trading volume of BMEA was 1.34M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
BMEA) stock’s latest price update
The stock of Biomea Fusion Inc (NASDAQ: BMEA) has decreased by -6.06 when compared to last closing price of 7.84. Despite this, the company has experienced a 17.46% gain in its stock price over the last five trading sessions. accesswire.com reported 2024-08-28 that LOS ANGELES, CA / ACCESSWIRE / August 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biomea Fusion, Inc. (“Biomea” or “the Company”) (NASDAQ:BMEA) violations of the securities laws. According to the Complaint, the Company made false and misleading statements to the market.
BMEA’s Market Performance
BMEA’s stock has risen by 17.46% in the past week, with a monthly rise of 38.44% and a quarterly drop of -32.37%. The volatility ratio for the week is 15.26% while the volatility levels for the last 30 days are 12.18% for Biomea Fusion Inc The simple moving average for the past 20 days is 20.00% for BMEA’s stock, with a -36.80% simple moving average for the past 200 days.
Analysts’ Opinion of BMEA
Barclays, on the other hand, stated in their research note that they expect to see BMEA reach a price target of $5, previously predicting the price at $30. The rating they have provided for BMEA stocks is “Equal Weight” according to the report published on June 07th, 2024.
JP Morgan gave a rating of “Neutral” to BMEA, setting the target price at $14 in the report published on April 02nd of the current year.
BMEA Trading at 34.36% from the 50-Day Moving Average
After a stumble in the market that brought BMEA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -67.61% of loss for the given period.
Volatility was left at 12.18%, however, over the last 30 days, the volatility rate increased by 15.26%, as shares surge +33.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +45.78% upper at present.
During the last 5 trading sessions, BMEA rose by +18.34%, which changed the moving average for the period of 200-days by -13.62% in comparison to the 20-day moving average, which settled at $6.23. In addition, Biomea Fusion Inc saw -49.28% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BMEA starting from Valle Franco, who purchase 12,509 shares at the price of $4.43 back on Jun 11 ’24. After this action, Valle Franco now owns 42,500 shares of Biomea Fusion Inc, valued at $55,361 using the latest closing price.
Stock Fundamentals for BMEA
Current profitability levels for the company are sitting at:
- -24.16 for the present operating margin
- 0.5 for the gross margin
The net margin for Biomea Fusion Inc stands at -22.74. The total capital return value is set at -1.34. Equity return is now at value -85.09, with -72.58 for asset returns.
Based on Biomea Fusion Inc (BMEA), the company’s capital structure generated 0.09 points at debt to capital in total, while cash flow to debt ratio is standing at -10.77. The debt to equity ratio resting at 0.1. The interest coverage ratio of the stock is -151.43.
Currently, EBITDA for the company is -121.93 million with net debt to EBITDA at 0.7. When we switch over and look at the enterprise to sales, we see a ratio of 26.42. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.62.
Conclusion
To sum up, Biomea Fusion Inc (BMEA) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
